Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
Factors Affecting Solubility
Chirality at Nitrogen, Phosphorus, and Sulfur
Stereoisomerism
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 11, 2026

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
1Center for Pharmaceutical Physics, Milford, NJ, USA.
Researchers evaluated the crystal forms of paroxetine hydrochloride, identifying four distinct polymorphic and four solvatomorphic structures. This study clarifies the known solid-state landscape for this important pharmaceutical compound.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: